Retinoblastoma seeds: impact on American Joint Committee on Cancer clinical staging
AimTo investigate whether the American Joint Committee on Cancer (AJCC) clinical category cT2b needs to be subclassified by the type and distribution of retinoblastoma (RB) seeding.MethodsMulticentre, international registry-based data were collected from RB centres enrolled between January 2001 and...
Saved in:
| Published in | British journal of ophthalmology Vol. 107; no. 1; pp. 127 - 132 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
BMA House, Tavistock Square, London, WC1H 9JR
BMJ Publishing Group Ltd
01.01.2023
BMJ Publishing Group LTD BMJ Publishing Group |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | AimTo investigate whether the American Joint Committee on Cancer (AJCC) clinical category cT2b needs to be subclassified by the type and distribution of retinoblastoma (RB) seeding.MethodsMulticentre, international registry-based data were collected from RB centres enrolled between January 2001 and December 2013. 1054 RB eyes with vitreous or subretinal seeds from 18 ophthalmic oncology centres, in 13 countries within six continents were analysed. Local treatment failure was defined as the use of secondary enucleation or external beam radiation therapy (EBRT) and was estimated with the Kaplan-Meier method.ResultsClinical category cT2b included 1054 eyes. Median age at presentation was 16.0 months. Of these, 428 (40.6%) eyes were salvaged, and 430 (40.8%) were treated with primary and 196 (18.6%) with secondary enucleation. Of the 592 eyes that had complete data for globe salvage analysis, the distribution of seeds was focal in 143 (24.2%) and diffuse in 449 (75.8%). The 5-year Kaplan-Meier cumulative globe-salvage (without EBRT) was 78% and 49% for eyes with focal and diffuse RB seeding, respectively. Cox proportional hazards regression analysis confirmed a higher local treatment failure risk with diffuse seeds as compared with focal seeds (hazard rate: 2.8; p<0.001). There was insufficient evidence to prove or disprove an association between vitreous seed type and local treatment failure risk(p=0.06).ConclusionThis international, multicentre, registry-based analysis of RB eyes affirmed that eyes with diffuse intraocular distribution of RB seeds at diagnosis had a higher risk of local treatment failure when compared with focal seeds. Subclassification of AJCC RB category cT2b into focal vs diffuse seeds will improve prognostication for eye salvage. |
|---|---|
| AbstractList | AIMTo investigate whether the American Joint Committee on Cancer (AJCC) clinical category cT2b needs to be subclassified by the type and distribution of retinoblastoma (RB) seeding. METHODSMulticentre, international registry-based data were collected from RB centres enrolled between January 2001 and December 2013. 1054 RB eyes with vitreous or subretinal seeds from 18 ophthalmic oncology centres, in 13 countries within six continents were analysed. Local treatment failure was defined as the use of secondary enucleation or external beam radiation therapy (EBRT) and was estimated with the Kaplan-Meier method. RESULTSClinical category cT2b included 1054 eyes. Median age at presentation was 16.0 months. Of these, 428 (40.6%) eyes were salvaged, and 430 (40.8%) were treated with primary and 196 (18.6%) with secondary enucleation. Of the 592 eyes that had complete data for globe salvage analysis, the distribution of seeds was focal in 143 (24.2%) and diffuse in 449 (75.8%). The 5-year Kaplan-Meier cumulative globe-salvage (without EBRT) was 78% and 49% for eyes with focal and diffuse RB seeding, respectively. Cox proportional hazards regression analysis confirmed a higher local treatment failure risk with diffuse seeds as compared with focal seeds (hazard rate: 2.8; p<0.001). There was insufficient evidence to prove or disprove an association between vitreous seed type and local treatment failure risk(p=0.06). CONCLUSIONThis international, multicentre, registry-based analysis of RB eyes affirmed that eyes with diffuse intraocular distribution of RB seeds at diagnosis had a higher risk of local treatment failure when compared with focal seeds. Subclassification of AJCC RB category cT2b into focal vs diffuse seeds will improve prognostication for eye salvage. To investigate whether the American Joint Committee on Cancer (AJCC) clinical category cT2b needs to be subclassified by the type and distribution of retinoblastoma (RB) seeding. Multicentre, international registry-based data were collected from RB centres enrolled between January 2001 and December 2013. 1054 RB eyes with vitreous or subretinal seeds from 18 ophthalmic oncology centres, in 13 countries within six continents were analysed. Local treatment failure was defined as the use of secondary enucleation or external beam radiation therapy (EBRT) and was estimated with the Kaplan-Meier method. Clinical category cT2b included 1054 eyes. Median age at presentation was 16.0 months. Of these, 428 (40.6%) eyes were salvaged, and 430 (40.8%) were treated with primary and 196 (18.6%) with secondary enucleation. Of the 592 eyes that had complete data for globe salvage analysis, the distribution of seeds was focal in 143 (24.2%) and diffuse in 449 (75.8%). The 5-year Kaplan-Meier cumulative globe-salvage (without EBRT) was 78% and 49% for eyes with focal and diffuse RB seeding, respectively. Cox proportional hazards regression analysis confirmed a higher local treatment failure risk with diffuse seeds as compared with focal seeds (hazard rate: 2.8; p<0.001). There was insufficient evidence to prove or disprove an association between vitreous seed type and local treatment failure risk(p=0.06). This international, multicentre, registry-based analysis of RB eyes affirmed that eyes with diffuse intraocular distribution of RB seeds at diagnosis had a higher risk of local treatment failure when compared with focal seeds. Subclassification of AJCC RB category cT2b into focal vs diffuse seeds will improve prognostication for eye salvage. Aim To investigate whether the American Joint Committee on Cancer (AJCC) clinical category cT2b needs to be subclassified by the type and distribution of retinoblastoma (RB) seeding. Methods Multicentre, international registry-based data were collected from RB centres enrolled between January 2001 and December 2013. 1054 RB eyes with vitreous or subretinal seeds from 18 ophthalmic oncology centres, in 13 countries within six continents were analysed. Local treatment failure was defined as the use of secondary enucleation or external beam radiation therapy (EBRT) and was estimated with the Kaplan-Meier method. Results Clinical category cT2b included 1054 eyes. Median age at presentation was 16.0 months. Of these, 428 (40.6%) eyes were salvaged, and 430 (40.8%) were treated with primary and 196 (18.6%) with secondary enucleation. Of the 592 eyes that had complete data for globe salvage analysis, the distribution of seeds was focal in 143 (24.2%) and diffuse in 449 (75.8%). The 5-year Kaplan-Meier cumulative globe-salvage (without EBRT) was 78% and 49% for eyes with focal and diffuse RB seeding, respectively. Cox proportional hazards regression analysis confirmed a higher local treatment failure risk with diffuse seeds as compared with focal seeds (hazard rate: 2.8; p<0.001). There was insufficient evidence to prove or disprove an association between vitreous seed type and local treatment failure risk(p=0.06). Conclusion This international, multicentre, registry-based analysis of RB eyes affirmed that eyes with diffuse intraocular distribution of RB seeds at diagnosis had a higher risk of local treatment failure when compared with focal seeds. Subclassification of AJCC RB category cT2b into focal vs diffuse seeds will improve prognostication for eye salvage. |
| Author | Desjardins, Laurence G Munier, Francis L Singh, Arun D Correa Llano, Maria Auw-Hädrich, Claudia Rouic, Livia Lumbroso-Le Murray, Timothy G Jager, Martine J Caroll, William L Moorthy, Sonia Heegaard, Steffen Yam, Jason C Doz, François Kivelä, Tero Pelayes, David E Ganeshan, Suganeswari Pe’er, Jacob Nummi, Kalle Coupland, Sarah E Semenova, Ekaterina Finger, Paul T Tomar, Ankit Singh Williams, Michelle Khetan, Vikas Gallie, Brenda Seregard, Stefan Kim, Jonathan Max Conway, R Graue, Gerardo F Lau, Winnie W Long, Quah Boon Zhao, Junyang Berry, Jesse L Chévez-Barrios, Patricia Essuman, Vera Adobea Yarovoy, Andrey Caminal, José M Jubran, Rima Rand Simpson, E Chantada, Guillermo L Brennan, Rachel Holbach, Leonard M Honavar, Santosh G Esmaeli, Bita Ushakova, Tatiana L Lam, Carol P Sharwood, Phillipa Washington, Mary Kay Esparza-Aguiar, Elizabeth Carreras, Elisa Polyakov, Vladimir G Wilson, Matthew Damato, Bertil E Mallipatna, Ashwin Zhang, Chengyue Ramirez-Ortiz, Marco Antonio Cassoux, Nathalie Rodriguez, Manuel Jorge Pierron, Gaelle Grossniklaus, Hans |
| AuthorAffiliation | 17 Russian Academy of Sciences , Moskva , Russian Federation 24 Retinoblastoma Unit, Department of Oncology , Hospital Sant Joan de Déu. Esplugues de Llobregat , Barcelona , Spain 16 Russian Academy of Postgraduate Medical Education , Moskva , Russian Federation 2 The Eye Cancer Clinic, Princess Margaret Cancer Centre, and Department of Ophthalmology and Vision Sciences , Hospital for Sick Children , Toronto , Ontario , Canada 11 Cancer and Blood Diseases , Childrens Hospital Society of Los Angeles , Los Angeles , California , USA 18 Department of Ophthalmology , Hospital Infantil de Mexico Federico Gomez , Mexico City , Mexico 15 Pediatric Oncology and Hematology , N N Blokhin NMRCO , Moskva , Russian Federation 27 Department of Child Health , University of Ghana Medical School , Accra , Greater Accra , Ghana 3 Ocular Oncology Service, Department of Ophthalmology , University of Helsinki and Helsinki University Hospital , Helsinki , Finland 4 Department of Ophthalmology and Vision Sciences , H |
| AuthorAffiliation_xml | – name: 25 KK Women's and Children's Hospital , Singapore – name: 8 Department of Ophthalmology , St Jude Children's Research Hospital , Memphis , Tennessee , USA – name: 11 Cancer and Blood Diseases , Childrens Hospital Society of Los Angeles , Los Angeles , California , USA – name: 24 Retinoblastoma Unit, Department of Oncology , Hospital Sant Joan de Déu. Esplugues de Llobregat , Barcelona , Spain – name: 19 Ophthalmology , Paediatric Hospital Dr Juan Garrahan Library , Buenos Aires , Argentina – name: 18 Department of Ophthalmology , Hospital Infantil de Mexico Federico Gomez , Mexico City , Mexico – name: 4 Department of Ophthalmology and Vision Sciences , Hospital for Sick Children , Toronto , Ontario , Canada – name: 1 Department of Ocular Tumor and Orbital Disease , New York Eye Cancer Center , New York , New York , USA – name: 13 Ocular Oncology Department , S Fyodorov Eye Microsurgery Federal State Institution , Moskva , Moskva , Russian Federation – name: 21 Opthamology and Visual Sciences , The Chinese University of Hong Kong Faculty of Medicine , Hong Kong , Hong Kong – name: 10 Department of Pediatrics , Children's Hospital Los Angeles , Los Angeles , California , USA – name: 5 Department of Ophthalmology and Vision Sciences , Narayana Nethralaya , Bangalore , Karnataka , India – name: 20 Precision Medicine Coordination Hospital J. P. Garrahan, and CONICET (National Scientific and Technical Research Council) , Buenos Aires , Argentina – name: 7 Ophthalmic Oncology, Department of Ophthalmology Hamilton Eye Institute , The University of Tennessee Health Science Center , Memphis , Tennessee , USA – name: 12 Vitreo Retinal Services , Sankara Nethralaya , Chennai , Tamil Nadu , India – name: 16 Russian Academy of Postgraduate Medical Education , Moskva , Russian Federation – name: 9 USC Roski Eye Institute , Keck Medical School of the University of Southern California, and The Vision Center at Children’s Hospital Los Angeles , Los Angeles , California , USA – name: 22 Department of Ophthalmology and Visual Sciences , Hong Kong Eye Hospital , Hong Kong , Hong Kong – name: 14 Department of Surgery (Ophthalmology) , King Hussein Cancer Center , Amman , Jordan – name: 26 Department of Child Heath , University of Ghana Medical School , Accra , Ghana – name: 3 Ocular Oncology Service, Department of Ophthalmology , University of Helsinki and Helsinki University Hospital , Helsinki , Finland – name: 23 Save Sight Institute, Discipline of Ophthalmology , The University of Sydney Sydney Medical School , Sydney , New South Wales , Australia – name: 28 Ophthalmology , Hospital Sant Joan de Deu , Barcelona , Catalunya , Spain – name: 17 Russian Academy of Sciences , Moskva , Russian Federation – name: 2 The Eye Cancer Clinic, Princess Margaret Cancer Centre, and Department of Ophthalmology and Vision Sciences , Hospital for Sick Children , Toronto , Ontario , Canada – name: 6 Pediatric Oncology Center , Beijing Children's Hospital , Beijing , China – name: 27 Department of Child Health , University of Ghana Medical School , Accra , Greater Accra , Ghana – name: 15 Pediatric Oncology and Hematology , N N Blokhin NMRCO , Moskva , Russian Federation |
| Author_xml | – sequence: 1 givenname: Ankit Singh surname: Tomar fullname: Tomar, Ankit Singh organization: Department of Ocular Tumor and Orbital Disease, New York Eye Cancer Center, New York, New York, USA – sequence: 2 givenname: Paul T orcidid: 0000-0002-8111-3896 surname: Finger fullname: Finger, Paul T email: pfinger@eyecancer.com organization: Department of Ocular Tumor and Orbital Disease, New York Eye Cancer Center, New York, New York, USA – sequence: 3 givenname: Brenda orcidid: 0000-0003-0503-4528 surname: Gallie fullname: Gallie, Brenda organization: The Eye Cancer Clinic, Princess Margaret Cancer Centre, and Department of Ophthalmology and Vision Sciences, Hospital for Sick Children, Toronto, Ontario, Canada – sequence: 4 givenname: Tero surname: Kivelä fullname: Kivelä, Tero organization: Ocular Oncology Service, Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland – sequence: 5 givenname: Ashwin surname: Mallipatna fullname: Mallipatna, Ashwin organization: Department of Ophthalmology and Vision Sciences, Narayana Nethralaya, Bangalore, Karnataka, India – sequence: 6 givenname: Chengyue surname: Zhang fullname: Zhang, Chengyue organization: Pediatric Oncology Center, Beijing Children's Hospital, Beijing, China – sequence: 7 givenname: Junyang surname: Zhao fullname: Zhao, Junyang organization: Pediatric Oncology Center, Beijing Children's Hospital, Beijing, China – sequence: 8 givenname: Matthew surname: Wilson fullname: Wilson, Matthew organization: Ophthalmic Oncology, Department of Ophthalmology Hamilton Eye Institute, The University of Tennessee Health Science Center, Memphis, Tennessee, USA – sequence: 9 givenname: Rachel orcidid: 0000-0002-2090-4395 surname: Brennan fullname: Brennan, Rachel organization: Department of Ophthalmology, St Jude Children's Research Hospital, Memphis, Tennessee, USA – sequence: 10 givenname: Michala surname: Burges fullname: Burges, Michala organization: Ophthalmic Oncology, Department of Ophthalmology Hamilton Eye Institute, The University of Tennessee Health Science Center, Memphis, Tennessee, USA – sequence: 11 givenname: Jonathan surname: Kim fullname: Kim, Jonathan organization: USC Roski Eye Institute, Keck Medical School of the University of Southern California, and The Vision Center at Children’s Hospital Los Angeles, Los Angeles, California, USA – sequence: 12 givenname: Jesse L orcidid: 0000-0002-8907-9100 surname: Berry fullname: Berry, Jesse L organization: Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA – sequence: 13 givenname: Rima surname: Jubran fullname: Jubran, Rima organization: Cancer and Blood Diseases, Childrens Hospital Society of Los Angeles, Los Angeles, California, USA – sequence: 14 givenname: Vikas surname: Khetan fullname: Khetan, Vikas organization: Vitreo Retinal Services, Sankara Nethralaya, Chennai, Tamil Nadu, India – sequence: 15 givenname: Suganeswari surname: Ganeshan fullname: Ganeshan, Suganeswari organization: Vitreo Retinal Services, Sankara Nethralaya, Chennai, Tamil Nadu, India – sequence: 16 givenname: Andrey surname: Yarovoy fullname: Yarovoy, Andrey organization: Ocular Oncology Department, S Fyodorov Eye Microsurgery Federal State Institution, Moskva, Moskva, Russian Federation – sequence: 17 givenname: Vera surname: Yarovaya fullname: Yarovaya, Vera organization: Ocular Oncology Department, S Fyodorov Eye Microsurgery Federal State Institution, Moskva, Moskva, Russian Federation – sequence: 18 givenname: Elena surname: Kotova fullname: Kotova, Elena organization: Ocular Oncology Department, S Fyodorov Eye Microsurgery Federal State Institution, Moskva, Moskva, Russian Federation – sequence: 19 givenname: Denis surname: Volodin fullname: Volodin, Denis organization: Ocular Oncology Department, S Fyodorov Eye Microsurgery Federal State Institution, Moskva, Moskva, Russian Federation – sequence: 20 givenname: Yacoub orcidid: 0000-0001-7750-6454 surname: Yousef fullname: Yousef, Yacoub organization: Department of Surgery (Ophthalmology), King Hussein Cancer Center, Amman, Jordan – sequence: 21 givenname: Kalle orcidid: 0000-0002-9497-1822 surname: Nummi fullname: Nummi, Kalle organization: Ocular Oncology Service, Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland – sequence: 22 givenname: Tatiana L surname: Ushakova fullname: Ushakova, Tatiana L organization: Russian Academy of Postgraduate Medical Education, Moskva, Russian Federation – sequence: 23 givenname: Olga V surname: Yugay fullname: Yugay, Olga V organization: Pediatric Oncology and Hematology, N N Blokhin NMRCO, Moskva, Russian Federation – sequence: 24 givenname: Vladimir G surname: Polyakov fullname: Polyakov, Vladimir G organization: Russian Academy of Sciences, Moskva, Russian Federation – sequence: 25 givenname: Marco Antonio surname: Ramirez-Ortiz fullname: Ramirez-Ortiz, Marco Antonio organization: Department of Ophthalmology, Hospital Infantil de Mexico Federico Gomez, Mexico City, Mexico – sequence: 26 givenname: Elizabeth surname: Esparza-Aguiar fullname: Esparza-Aguiar, Elizabeth organization: Department of Ophthalmology, Hospital Infantil de Mexico Federico Gomez, Mexico City, Mexico – sequence: 27 givenname: Guillermo L surname: Chantada fullname: Chantada, Guillermo L organization: Ophthalmology, Paediatric Hospital Dr Juan Garrahan Library, Buenos Aires, Argentina – sequence: 28 givenname: Paula surname: Schaiquevich fullname: Schaiquevich, Paula organization: Precision Medicine Coordination Hospital J. P. Garrahan, and CONICET (National Scientific and Technical Research Council), Buenos Aires, Argentina – sequence: 29 givenname: Adriana C surname: Fandiño fullname: Fandiño, Adriana C organization: Ophthalmology, Paediatric Hospital Dr Juan Garrahan Library, Buenos Aires, Argentina – sequence: 30 givenname: Jason C orcidid: 0000-0002-2156-1486 surname: Yam fullname: Yam, Jason C organization: Opthamology and Visual Sciences, The Chinese University of Hong Kong Faculty of Medicine, Hong Kong, Hong Kong – sequence: 31 givenname: Winnie W surname: Lau fullname: Lau, Winnie W organization: Department of Ophthalmology and Visual Sciences, Hong Kong Eye Hospital, Hong Kong, Hong Kong – sequence: 32 givenname: Carol P surname: Lam fullname: Lam, Carol P organization: Department of Ophthalmology and Visual Sciences, Hong Kong Eye Hospital, Hong Kong, Hong Kong – sequence: 33 givenname: Phillipa surname: Sharwood fullname: Sharwood, Phillipa organization: Save Sight Institute, Discipline of Ophthalmology, The University of Sydney Sydney Medical School, Sydney, New South Wales, Australia – sequence: 34 givenname: Sonia surname: Moorthy fullname: Moorthy, Sonia organization: Retinoblastoma Unit, Department of Oncology, Hospital Sant Joan de Déu. Esplugues de Llobregat, Barcelona, Spain – sequence: 35 givenname: Quah Boon surname: Long fullname: Long, Quah Boon organization: KK Women's and Children's Hospital, Singapore – sequence: 36 givenname: Vera Adobea surname: Essuman fullname: Essuman, Vera Adobea organization: Department of Child Heath, University of Ghana Medical School, Accra, Ghana – sequence: 37 givenname: Lorna A surname: Renner fullname: Renner, Lorna A organization: Department of Child Health, University of Ghana Medical School, Accra, Greater Accra, Ghana – sequence: 38 givenname: Ekaterina surname: Semenova fullname: Semenova, Ekaterina organization: Department of Ocular Tumor and Orbital Disease, New York Eye Cancer Center, New York, New York, USA – sequence: 39 givenname: Jaume surname: Català-Mora fullname: Català-Mora, Jaume organization: Ophthalmology, Hospital Sant Joan de Deu, Barcelona, Catalunya, Spain – sequence: 40 givenname: Maria surname: Correa Llano fullname: Correa Llano, Maria organization: Ophthalmology, Hospital Sant Joan de Deu, Barcelona, Catalunya, Spain – sequence: 41 givenname: Elisa surname: Carreras fullname: Carreras, Elisa organization: Ophthalmology, Hospital Sant Joan de Deu, Barcelona, Catalunya, Spain – sequence: 42 givenname: Sarah E surname: Coupland fullname: Coupland, Sarah E – sequence: 43 givenname: Daniel M surname: Albert fullname: Albert, Daniel M – sequence: 44 givenname: Anush G surname: Amiryan fullname: Amiryan, Anush G – sequence: 45 givenname: Svetlana surname: Saakyan fullname: Saakyan, Svetlana – sequence: 46 givenname: Claudia surname: Auw-Hädrich fullname: Auw-Hädrich, Claudia – sequence: 47 givenname: Diane surname: Baker fullname: Baker, Diane – sequence: 48 givenname: Raymond surname: Barnhill fullname: Barnhill, Raymond – sequence: 49 givenname: José M surname: Caminal fullname: Caminal, José M – sequence: 50 givenname: William L surname: Caroll fullname: Caroll, William L – sequence: 51 givenname: Nathalie surname: Cassoux fullname: Cassoux, Nathalie – sequence: 52 givenname: Laurence G surname: Desjardins fullname: Desjardins, Laurence G – sequence: 53 givenname: François surname: Doz fullname: Doz, François – sequence: 54 givenname: Gaelle surname: Pierron fullname: Pierron, Gaelle – sequence: 55 givenname: Patricia surname: Chévez-Barrios fullname: Chévez-Barrios, Patricia – sequence: 56 givenname: R surname: Max Conway fullname: Max Conway, R – sequence: 57 givenname: Bertil E surname: Damato fullname: Damato, Bertil E – sequence: 58 givenname: Hakan surname: Demirci fullname: Demirci, Hakan – sequence: 59 givenname: Jonathan J surname: Dutton fullname: Dutton, Jonathan J – sequence: 60 givenname: Bita surname: Esmaeli fullname: Esmaeli, Bita – sequence: 61 givenname: Victor G surname: Prieto fullname: Prieto, Victor G – sequence: 62 givenname: Michelle surname: Williams fullname: Williams, Michelle – sequence: 63 givenname: Brenda L surname: Gallie fullname: Gallie, Brenda L – sequence: 64 givenname: Gerardo F surname: Graue fullname: Graue, Gerardo F – sequence: 65 givenname: Hans E surname: Grossniklaus fullname: Grossniklaus, Hans E – sequence: 66 givenname: Steffen surname: Heegaard fullname: Heegaard, Steffen – sequence: 67 givenname: Leonard M surname: Holbach fullname: Holbach, Leonard M – sequence: 68 givenname: Santosh G surname: Honavar fullname: Honavar, Santosh G – sequence: 69 givenname: Martine J surname: Jager fullname: Jager, Martine J – sequence: 70 givenname: Emma surname: Kujala fullname: Kujala, Emma – sequence: 71 givenname: Livia Lumbroso-Le surname: Rouic fullname: Rouic, Livia Lumbroso-Le – sequence: 72 givenname: Giulio M surname: Modorati fullname: Modorati, Giulio M – sequence: 73 givenname: Francis L surname: Munier fullname: Munier, Francis L – sequence: 74 givenname: Timothy G surname: Murray fullname: Murray, Timothy G – sequence: 75 givenname: Anna C surname: Pavlick fullname: Pavlick, Anna C – sequence: 76 givenname: Jacob surname: Pe’er fullname: Pe’er, Jacob – sequence: 77 givenname: David E surname: Pelayes fullname: Pelayes, David E – sequence: 78 givenname: Manuel Jorge surname: Rodriguez fullname: Rodriguez, Manuel Jorge – sequence: 79 givenname: Wolfgang AG surname: Sauerwein fullname: Sauerwein, Wolfgang AG – sequence: 80 givenname: Stefan surname: Seregard fullname: Seregard, Stefan – sequence: 81 givenname: Carol surname: Shields fullname: Shields, Carol – sequence: 82 givenname: E surname: Rand Simpson fullname: Rand Simpson, E – sequence: 83 givenname: Arun D surname: Singh fullname: Singh, Arun D – sequence: 84 givenname: Shigenobu surname: Suzuki fullname: Suzuki, Shigenobu – sequence: 85 givenname: Mary Kay surname: Washington fullname: Washington, Mary Kay – sequence: 86 givenname: Valerie A surname: White fullname: White, Valerie A – sequence: 87 givenname: Mathew W surname: Wilson fullname: Wilson, Mathew W – sequence: 88 givenname: Christian W surname: Wittekind fullname: Wittekind, Christian W – sequence: 89 givenname: Vivian surname: Yin fullname: Yin, Vivian |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34340974$$D View this record in MEDLINE/PubMed http://kipublications.ki.se/Default.aspx?queryparsed=id:148270371$$DView record from Swedish Publication Index |
| BookMark | eNqVkV9vFCEUxYlpY7fVr2Am8cWXUWBgYHwwaTZq2zQx8c8zYZg7u6wDrMDa9NvLZta19cX4QIB7f-fkwjlHJz54QKgi-DUhTfum34TtOq_15MJUU0xJ3RApO_oELQhrZSmJ7gQtMMaiJqQlZ-g8pU250paIp-isYQ3DnWAL9OUzZOtDP-mUg9NVAhjS28q6rTa5Cr66dBCt0b66CdbnahmcszkD7HtL7Q3EykzWF2SqUtYr61fP0OmopwTPD_sF-vbh_dflVX376eP18vK27lvKc00azQXGWppWGgls6MkwGm4MpmM3ag5QJpfQAWPj2PNmZP2IWw0CNx1nVDYXqJt90x1sd73aRut0vFdB23IOgzrUv9v9UgkUYZIWuSBF-27WFsDBYMDnqKfHFo863q7VKvxUHcVccFYMXh0MYvixg5SVs8nANGkPYZcU5QXjmHBa0Jd_oZuwi758jaLFqmOtELxQcqZMDClFGI_DEKz2qauHqat96mpOvUhfPHzMUfg75gI0M9C7zf_Ysj-q48j_lP0CJGnSew |
| CitedBy_id | crossref_primary_10_1016_S2214_109X_21_00555_6 crossref_primary_10_1007_s12098_024_05085_2 crossref_primary_10_1148_rg_230125 crossref_primary_10_1016_S2214_109X_21_00598_2 crossref_primary_10_1111_ceo_14357 crossref_primary_10_1016_j_apjo_2024_100058 |
| Cites_doi | 10.1016/j.ophtha.2020.05.050 10.1016/j.ophtha.2020.05.051 10.1016/j.ophtha.2013.09.011 10.1007/s10384-020-00743-2 10.1155/2020/8628525 10.1016/j.ophtha.2017.04.015 10.1167/iovs.12-9501 10.1016/j.ophtha.2016.02.036 10.1016/j.ophtha.2017.05.034 10.1016/j.ophtha.2020.09.032 10.1016/j.ophtha.2011.02.005 10.1016/j.ophtha.2006.06.018 10.4103/ijo.IJO_737_18 10.3109/13816810.2014.973045 10.1016/j.ohc.2004.11.003 |
| ContentType | Journal Article |
| Contributor | Desjardins, Laurence G Munier, Francis L Singh, Arun D Washington, Mary Kay Damato, Bertil E Auw-Hädrich, Claudia Rouic, Livia Lumbroso-Le Murray, Timothy G Cassoux, Nathalie Rodriguez, Manuel Jorge Jager, Martine J Sauerwein, Wolfgang Ag Caroll, William L Pierron, Gaelle Grossniklaus, Hans E Gallie, Brenda L Heegaard, Steffen Wilson, Mathew W Doz, François Prieto, Victor G Kujala, Emma Pelayes, David E Dutton, Jonathan J Coupland, Sarah E Williams, Michelle Albert, Daniel M Modorati, Giulio M Seregard, Stefan Pavlick, Anna C Yin, Vivian Max Conway, R Graue, Gerardo F Pe'er, Jacob Wittekind, Christian W Chévez-Barrios, Patricia White, Valerie A Baker, Diane Shields, Carol Suzuki, Shigenobu Saakyan, Svetlana Amiryan, Anush G Caminal, José M Rand Simpson, E Demirci, Hakan Barnhill, Raymond Holbach, Leonard M Honavar, Santosh G Esmaeli, Bita |
| Contributor_xml | – sequence: 1 givenname: Sarah E surname: Coupland fullname: Coupland, Sarah E – sequence: 2 givenname: Daniel M surname: Albert fullname: Albert, Daniel M – sequence: 3 givenname: Anush G surname: Amiryan fullname: Amiryan, Anush G – sequence: 4 givenname: Svetlana surname: Saakyan fullname: Saakyan, Svetlana – sequence: 5 givenname: Claudia surname: Auw-Hädrich fullname: Auw-Hädrich, Claudia – sequence: 6 givenname: Diane surname: Baker fullname: Baker, Diane – sequence: 7 givenname: Raymond surname: Barnhill fullname: Barnhill, Raymond – sequence: 8 givenname: José M surname: Caminal fullname: Caminal, José M – sequence: 9 givenname: William L surname: Caroll fullname: Caroll, William L – sequence: 10 givenname: Nathalie surname: Cassoux fullname: Cassoux, Nathalie – sequence: 11 givenname: Laurence G surname: Desjardins fullname: Desjardins, Laurence G – sequence: 12 givenname: François surname: Doz fullname: Doz, François – sequence: 13 givenname: Gaelle surname: Pierron fullname: Pierron, Gaelle – sequence: 14 givenname: Patricia surname: Chévez-Barrios fullname: Chévez-Barrios, Patricia – sequence: 15 givenname: R surname: Max Conway fullname: Max Conway, R – sequence: 16 givenname: Bertil E surname: Damato fullname: Damato, Bertil E – sequence: 17 givenname: Hakan surname: Demirci fullname: Demirci, Hakan – sequence: 18 givenname: Jonathan J surname: Dutton fullname: Dutton, Jonathan J – sequence: 19 givenname: Bita surname: Esmaeli fullname: Esmaeli, Bita – sequence: 20 givenname: Victor G surname: Prieto fullname: Prieto, Victor G – sequence: 21 givenname: Michelle surname: Williams fullname: Williams, Michelle – sequence: 22 givenname: Brenda L surname: Gallie fullname: Gallie, Brenda L – sequence: 23 givenname: Gerardo F surname: Graue fullname: Graue, Gerardo F – sequence: 24 givenname: Hans E surname: Grossniklaus fullname: Grossniklaus, Hans E – sequence: 25 givenname: Steffen surname: Heegaard fullname: Heegaard, Steffen – sequence: 26 givenname: Leonard M surname: Holbach fullname: Holbach, Leonard M – sequence: 27 givenname: Santosh G surname: Honavar fullname: Honavar, Santosh G – sequence: 28 givenname: Martine J surname: Jager fullname: Jager, Martine J – sequence: 29 givenname: Emma surname: Kujala fullname: Kujala, Emma – sequence: 30 givenname: Livia Lumbroso-Le surname: Rouic fullname: Rouic, Livia Lumbroso-Le – sequence: 31 givenname: Giulio M surname: Modorati fullname: Modorati, Giulio M – sequence: 32 givenname: Francis L surname: Munier fullname: Munier, Francis L – sequence: 33 givenname: Timothy G surname: Murray fullname: Murray, Timothy G – sequence: 34 givenname: Anna C surname: Pavlick fullname: Pavlick, Anna C – sequence: 35 givenname: Jacob surname: Pe'er fullname: Pe'er, Jacob – sequence: 36 givenname: David E surname: Pelayes fullname: Pelayes, David E – sequence: 37 givenname: Manuel Jorge surname: Rodriguez fullname: Rodriguez, Manuel Jorge – sequence: 38 givenname: Wolfgang Ag surname: Sauerwein fullname: Sauerwein, Wolfgang Ag – sequence: 39 givenname: Stefan surname: Seregard fullname: Seregard, Stefan – sequence: 40 givenname: Carol surname: Shields fullname: Shields, Carol – sequence: 41 givenname: E surname: Rand Simpson fullname: Rand Simpson, E – sequence: 42 givenname: Arun D surname: Singh fullname: Singh, Arun D – sequence: 43 givenname: Shigenobu surname: Suzuki fullname: Suzuki, Shigenobu – sequence: 44 givenname: Mary Kay surname: Washington fullname: Washington, Mary Kay – sequence: 45 givenname: Valerie A surname: White fullname: White, Valerie A – sequence: 46 givenname: Mathew W surname: Wilson fullname: Wilson, Mathew W – sequence: 47 givenname: Christian W surname: Wittekind fullname: Wittekind, Christian W – sequence: 48 givenname: Vivian surname: Yin fullname: Yin, Vivian |
| Copyright | Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023 |
| Copyright_xml | – notice: Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. – notice: Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. – notice: 2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023 |
| CorporateAuthor | The American Joint Committee on Cancer Ophthalmic Oncology Task American Joint Committee on Cancer Ophthalmic Oncology Task American Joint Committee on Cancer Ophthalmic Oncology Task Force |
| CorporateAuthor_xml | – name: American Joint Committee on Cancer Ophthalmic Oncology Task – name: American Joint Committee on Cancer Ophthalmic Oncology Task Force |
| DBID | 9YT ACMMV CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR BTHHO CCPQU FYUFA GHDGH K9. M0S M1P PQEST PQQKQ PQUKI PRINS 7X8 5PM ADTPV AOWAS D8T ZZAVC |
| DOI | 10.1136/bjophthalmol-2021-318892 |
| DatabaseName | BMJ Open Access Journals BMJ Journals:Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) ProQuest_Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central BMJ Journals ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) SwePub SwePub Articles SWEPUB Freely available online SwePub Articles full text |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) BMJ Journals ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef ProQuest One Academic Eastern Edition |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: ACMMV name: BMJ Journals:Open Access url: https://journals.bmj.com/ sourceTypes: Publisher – sequence: 4 dbid: 7X7 name: ProQuest_Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1468-2079 |
| EndPage | 132 |
| ExternalDocumentID | oai_prod_swepub_kib_ki_se_148270371 10_1136_bjophthalmol_2021_318892 34340974 ttps://bjo.bmj.com/content/early/2021/08/01/bjophthalmol-2021-318892.full ttps://bjo.bmj.com/content/107/1/127.full |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | New York United States--US |
| GeographicLocations_xml | – name: New York – name: United States--US |
| GrantInformation_xml | – fundername: The Eye Cancer Foundation grantid: Fellowship Grant – fundername: The Myrna and John Daniels Charitable Trust grantid: Internet Technology Grant – fundername: The Paul T Finger Fund at Princess Margaret Cancer Centre grantid: Retinoblastoma Grant #003 – fundername: The Helsinki University Hospital Research Fund grantid: In support of Tero Kivela MD – fundername: NCI NIH HHS grantid: K08 CA232344 – fundername: ; grantid: In support of Tero Kivela MD – fundername: ; grantid: Fellowship Grant – fundername: ; grantid: Retinoblastoma Grant #003 – fundername: ; grantid: Internet Technology Grant |
| GroupedDBID | --- -~X .55 .VT 0R~ 18M 23N 2WC 39C 4.4 40O 5GY 5RE 5VS 6J9 7X7 7~S 88E 8FI 8FJ 9YT AAHLL AAOJX AAWJN ABAAH ABJNI ABKDF ABMQD ABTFR ABUWG ABVAJ ACGFO ACGFS ACGTL ACHTP ACMFJ ACMMV ACNCT ACOFX ACTZY ADBBV AENEX AFKRA AFWFF AHMBA AHNKE AHQMW AJYBZ ALIPV ALMA_UNASSIGNED_HOLDINGS BAWUL BENPR BLJBA BOMFT BPHCQ BTHHO BVXVI C45 CCPQU CS3 CXRWF DU5 E3Z EBS F5P FYUFA H13 HAJ HMCUK HZ~ IAO IOF L7B M1P N9A NXWIF O9- OVD P2P PQQKQ PROAC PSQYO RHF RHI RMJ RPM RV8 TEORI TR2 UAW UKHRP UYXKK V24 VM9 WH7 X7M YFH YQY .GJ 354 3O- 3V. 53G 8R4 8R5 AAKAS ACCCW ADCEG ADZCM ASPBG AVWKF AZFZN BTFSW C1A CAG CGR COF CUY CVF DIK ECM EIF EJD HYE IEA IHR ITC J5H KQ8 NPM NTWIH OK1 Q2X R53 W8F WOQ XOL ZGI AAYXX CITATION 7XB 8FK K9. PQEST PQUKI PRINS 7X8 5PM ADTPV AOWAS D8T ZZAVC |
| ID | FETCH-LOGICAL-b625t-13a5700a8c68c8e4db1dfc5cc02f9fa5ee1618e9e44ffb53f4bf06ae703954283 |
| IEDL.DBID | 9YT |
| ISSN | 0007-1161 1468-2079 |
| IngestDate | Wed Oct 30 05:03:30 EDT 2024 Tue Sep 17 21:32:26 EDT 2024 Fri Oct 25 02:17:23 EDT 2024 Thu Oct 10 15:53:52 EDT 2024 Fri Aug 23 01:01:37 EDT 2024 Sat Sep 28 08:22:30 EDT 2024 Wed Aug 21 03:27:00 EDT 2024 Wed Aug 21 02:07:16 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | vitreous pathology retina neoplasia |
| Language | English |
| License | This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b625t-13a5700a8c68c8e4db1dfc5cc02f9fa5ee1618e9e44ffb53f4bf06ae703954283 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-9497-1822 0000-0002-8907-9100 0000-0002-2156-1486 0000-0002-2090-4395 0000-0003-0503-4528 0000-0001-7750-6454 0000-0002-8111-3896 |
| OpenAccessLink | http://dx.doi.org/10.1136/bjophthalmol-2021-318892 |
| PMID | 34340974 |
| PQID | 2754946775 |
| PQPubID | 2041039 |
| PageCount | 6 |
| ParticipantIDs | swepub_primary_oai_prod_swepub_kib_ki_se_148270371 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9205754 proquest_miscellaneous_2557550152 proquest_journals_2754946775 crossref_primary_10_1136_bjophthalmol_2021_318892 pubmed_primary_34340974 bmj_primary_10_1136_bjophthalmol_2021_318892 bmj_journals_10_1136_bjophthalmol_2021_318892 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-01-01 |
| PublicationDateYYYYMMDD | 2023-01-01 |
| PublicationDate_xml | – month: 01 year: 2023 text: 2023-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | BMA House, Tavistock Square, London, WC1H 9JR |
| PublicationPlace_xml | – name: BMA House, Tavistock Square, London, WC1H 9JR – name: England – name: London |
| PublicationTitle | British journal of ophthalmology |
| PublicationTitleAbbrev | Br J Ophthalmol |
| PublicationTitleAlternate | Br J Ophthalmol |
| PublicationYear | 2023 |
| Publisher | BMJ Publishing Group Ltd BMJ Publishing Group LTD BMJ Publishing Group |
| Publisher_xml | – name: BMJ Publishing Group Ltd – name: BMJ Publishing Group LTD – name: BMJ Publishing Group |
| References | Francis, Marr, Abramson (R6) 2016; 123 Munier (R1) 2014; 35 Amram, Rico, Kim (R2) 2017; 124 Sthapit, Rao, Honavar (R11) 2018; 66 Shields, Mashayekhi, Au (R9) 2006; 113 Tomar, Finger, Gallie (R13) 2020 Kivelä, Eskelin, Paloheimo (R16) 2011; 118 Manjandavida, Honavar, Reddy (R5) 2014; 121 Yousef, Noureldin, Sultan (R3) 2020; 2020 Reese, Ellsworth (R7) 1963; 67 Tomar, Finger, Gallie (R14) 2020 Schaiquevich, Buitrago, Taich (R17) 2012; 53 Linn Murphree (R8) 2005; 18 Kiratli, Koç, Öztürk (R4) 2020; 64 Berry, Bechtold, Shah (R12) 2017; 124 Tomar, Finger, Gallie (R15) 2021; 128 Kiratli, Koç, Öztürk 2020; 64 Tomar, Finger, Gallie 2020 Amram, Rico, Kim 2017; 124 Munier 2014; 35 Linn Murphree 2005; 18 Francis, Marr, Abramson 2016; 123 Tomar, Finger, Gallie 2021; 128 Shields, Mashayekhi, Au 2006; 113 Schaiquevich, Buitrago, Taich 2012; 53 Kivelä, Eskelin, Paloheimo 2011; 118 Manjandavida, Honavar, Reddy 2014; 121 Berry, Bechtold, Shah 2017; 124 Reese, Ellsworth 1963; 67 Yousef, Noureldin, Sultan 2020; 2020 Sthapit, Rao, Honavar 2018; 66 Tomar (2023010523100927000_107.1.127.15) 2021; 128 2023010523100927000_107.1.127.9 2023010523100927000_107.1.127.8 Amram (2023010523100927000_107.1.127.2) 2017; 124 Francis (2023010523100927000_107.1.127.6) 2016; 123 2023010523100927000_107.1.127.1 Kiratli (2023010523100927000_107.1.127.4) 2020; 64 Manjandavida (2023010523100927000_107.1.127.5) 2014; 121 Berry (2023010523100927000_107.1.127.12) 2017; 124 2023010523100927000_107.1.127.16 2023010523100927000_107.1.127.17 2023010523100927000_107.1.127.14 Sthapit (2023010523100927000_107.1.127.11) 2018; 66 2023010523100927000_107.1.127.13 2023010523100927000_107.1.127.10 Yousef (2023010523100927000_107.1.127.3) 2020; 2020 Reese (2023010523100927000_107.1.127.7) 1963; 67 |
| References_xml | – year: 2020 ident: R13 article-title: A multicenter, international collaborative study for AJCC-Staging of retinoblastoma: metastasis-associated mortality publication-title: Ophthalmology doi: 10.1016/j.ophtha.2020.05.050 contributor: fullname: Gallie – year: 2020 ident: R14 article-title: A multicenter, international collaborative study for AJCC-Staging of retinoblastoma: treatment success and globe salvage publication-title: Ophthalmology doi: 10.1016/j.ophtha.2020.05.051 contributor: fullname: Gallie – volume: 121 start-page: 517 year: 2014 ident: R5 article-title: Management and outcome of retinoblastoma with vitreous seeds publication-title: Ophthalmology doi: 10.1016/j.ophtha.2013.09.011 contributor: fullname: Reddy – volume: 64 start-page: 351 year: 2020 ident: R4 article-title: Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma publication-title: Jpn J Ophthalmol doi: 10.1007/s10384-020-00743-2 contributor: fullname: Öztürk – volume: 2020 year: 2020 ident: R3 article-title: Intravitreal melphalan chemotherapy for vitreous seeds in retinoblastoma publication-title: J Ophthalmol doi: 10.1155/2020/8628525 contributor: fullname: Sultan – volume: 124 start-page: 1540 year: 2017 ident: R2 article-title: Vitreous seeds in retinoblastoma: clinicopathologic classification and correlation publication-title: Ophthalmology doi: 10.1016/j.ophtha.2017.04.015 contributor: fullname: Kim – volume: 53 start-page: 4205 year: 2012 ident: R17 article-title: Pharmacokinetic analysis of melphalan after superselective ophthalmic artery infusion in preclinical models and retinoblastoma patients publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.12-9501 contributor: fullname: Taich – volume: 123 start-page: 1601 year: 2016 ident: R6 article-title: Classification of vitreous seeds in retinoblastoma: correlations with patient, tumor, and treatment characteristics publication-title: Ophthalmology doi: 10.1016/j.ophtha.2016.02.036 contributor: fullname: Abramson – volume: 124 start-page: 1817 year: 2017 ident: R12 article-title: Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma publication-title: Ophthalmology doi: 10.1016/j.ophtha.2017.05.034 contributor: fullname: Shah – volume: 128 year: 2021 ident: R15 article-title: Global retinoblastoma treatment outcomes: association with national income level publication-title: Ophthalmology doi: 10.1016/j.ophtha.2020.09.032 contributor: fullname: Gallie – volume: 118 start-page: 1689 year: 2011 ident: R16 article-title: Intravitreal methotrexate for retinoblastoma publication-title: Ophthalmology doi: 10.1016/j.ophtha.2011.02.005 contributor: fullname: Paloheimo – volume: 113 start-page: 2276 year: 2006 ident: R9 article-title: The International classification of retinoblastoma predicts chemoreduction success publication-title: Ophthalmology doi: 10.1016/j.ophtha.2006.06.018 contributor: fullname: Au – volume: 66 start-page: 1833 year: 2018 ident: R11 article-title: Periocular topotecan for vitreous seeds in retinoblastoma publication-title: Indian J Ophthalmol doi: 10.4103/ijo.IJO_737_18 contributor: fullname: Honavar – volume: 35 start-page: 193 year: 2014 ident: R1 article-title: Classification and management of seeds in retinoblastoma. Ellsworth lecture Ghent August 24th 2013 publication-title: Ophthalmic Genet doi: 10.3109/13816810.2014.973045 contributor: fullname: Munier – volume: 67 start-page: 164 year: 1963 ident: R7 article-title: The evaluation and current concept of retinoblastoma therapy publication-title: Trans Am Acad Ophthalmol Otolaryngol contributor: fullname: Ellsworth – volume: 18 start-page: 41 year: 2005 ident: R8 article-title: Intraocular retinoblastoma: the case for a new group classification publication-title: Ophthalmol Clin North Am doi: 10.1016/j.ohc.2004.11.003 contributor: fullname: Linn Murphree – volume: 123 start-page: 1601 year: 2016 article-title: Classification of vitreous seeds in retinoblastoma: correlations with patient, tumor, and treatment characteristics publication-title: Ophthalmology doi: 10.1016/j.ophtha.2016.02.036 contributor: fullname: Abramson – volume: 67 start-page: 164 year: 1963 article-title: The evaluation and current concept of retinoblastoma therapy publication-title: Trans Am Acad Ophthalmol Otolaryngol contributor: fullname: Ellsworth – volume: 66 start-page: 1833 year: 2018 article-title: Periocular topotecan for vitreous seeds in retinoblastoma publication-title: Indian J Ophthalmol doi: 10.4103/ijo.IJO_737_18 contributor: fullname: Honavar – volume: 113 start-page: 2276 year: 2006 article-title: The International classification of retinoblastoma predicts chemoreduction success publication-title: Ophthalmology doi: 10.1016/j.ophtha.2006.06.018 contributor: fullname: Au – volume: 124 start-page: 1540 year: 2017 article-title: Vitreous seeds in retinoblastoma: clinicopathologic classification and correlation publication-title: Ophthalmology doi: 10.1016/j.ophtha.2017.04.015 contributor: fullname: Kim – volume: 128 year: 2021 article-title: Global retinoblastoma treatment outcomes: association with national income level publication-title: Ophthalmology doi: 10.1016/j.ophtha.2020.09.032 contributor: fullname: Gallie – volume: 121 start-page: 517 year: 2014 article-title: Management and outcome of retinoblastoma with vitreous seeds publication-title: Ophthalmology doi: 10.1016/j.ophtha.2013.09.011 contributor: fullname: Reddy – volume: 118 start-page: 1689 year: 2011 article-title: Intravitreal methotrexate for retinoblastoma publication-title: Ophthalmology doi: 10.1016/j.ophtha.2011.02.005 contributor: fullname: Paloheimo – volume: 124 start-page: 1817 year: 2017 article-title: Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma publication-title: Ophthalmology doi: 10.1016/j.ophtha.2017.05.034 contributor: fullname: Shah – year: 2020 article-title: A multicenter, international collaborative study for AJCC-Staging of retinoblastoma: treatment success and globe salvage publication-title: Ophthalmology doi: 10.1016/j.ophtha.2020.05.051 contributor: fullname: Gallie – volume: 53 start-page: 4205 year: 2012 article-title: Pharmacokinetic analysis of melphalan after superselective ophthalmic artery infusion in preclinical models and retinoblastoma patients publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.12-9501 contributor: fullname: Taich – volume: 18 start-page: 41 year: 2005 article-title: Intraocular retinoblastoma: the case for a new group classification publication-title: Ophthalmol Clin North Am doi: 10.1016/j.ohc.2004.11.003 contributor: fullname: Linn Murphree – volume: 35 start-page: 193 year: 2014 article-title: Classification and management of seeds in retinoblastoma. Ellsworth lecture Ghent August 24th 2013 publication-title: Ophthalmic Genet doi: 10.3109/13816810.2014.973045 contributor: fullname: Munier – volume: 64 start-page: 351 year: 2020 article-title: Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma publication-title: Jpn J Ophthalmol doi: 10.1007/s10384-020-00743-2 contributor: fullname: Öztürk – year: 2020 article-title: A multicenter, international collaborative study for AJCC-Staging of retinoblastoma: metastasis-associated mortality publication-title: Ophthalmology doi: 10.1016/j.ophtha.2020.05.050 contributor: fullname: Gallie – volume: 2020 year: 2020 article-title: Intravitreal melphalan chemotherapy for vitreous seeds in retinoblastoma publication-title: J Ophthalmol doi: 10.1155/2020/8628525 contributor: fullname: Sultan – volume: 123 start-page: 1601 year: 2016 ident: 2023010523100927000_107.1.127.6 article-title: Classification of vitreous seeds in retinoblastoma: correlations with patient, tumor, and treatment characteristics publication-title: Ophthalmology doi: 10.1016/j.ophtha.2016.02.036 contributor: fullname: Francis – ident: 2023010523100927000_107.1.127.1 doi: 10.3109/13816810.2014.973045 – volume: 2020 year: 2020 ident: 2023010523100927000_107.1.127.3 article-title: Intravitreal melphalan chemotherapy for vitreous seeds in retinoblastoma publication-title: J Ophthalmol doi: 10.1155/2020/8628525 contributor: fullname: Yousef – ident: 2023010523100927000_107.1.127.9 doi: 10.1016/j.ophtha.2006.06.018 – ident: 2023010523100927000_107.1.127.16 doi: 10.1016/j.ophtha.2011.02.005 – ident: 2023010523100927000_107.1.127.8 doi: 10.1016/j.ohc.2004.11.003 – volume: 124 start-page: 1540 year: 2017 ident: 2023010523100927000_107.1.127.2 article-title: Vitreous seeds in retinoblastoma: clinicopathologic classification and correlation publication-title: Ophthalmology doi: 10.1016/j.ophtha.2017.04.015 contributor: fullname: Amram – volume: 67 start-page: 164 year: 1963 ident: 2023010523100927000_107.1.127.7 article-title: The evaluation and current concept of retinoblastoma therapy publication-title: Trans Am Acad Ophthalmol Otolaryngol contributor: fullname: Reese – volume: 66 start-page: 1833 year: 2018 ident: 2023010523100927000_107.1.127.11 article-title: Periocular topotecan for vitreous seeds in retinoblastoma publication-title: Indian J Ophthalmol doi: 10.4103/ijo.IJO_737_18 contributor: fullname: Sthapit – volume: 128 year: 2021 ident: 2023010523100927000_107.1.127.15 article-title: Global retinoblastoma treatment outcomes: association with national income level publication-title: Ophthalmology doi: 10.1016/j.ophtha.2020.09.032 contributor: fullname: Tomar – ident: 2023010523100927000_107.1.127.14 doi: 10.1016/j.ophtha.2020.05.051 – ident: 2023010523100927000_107.1.127.13 doi: 10.1016/j.ophtha.2020.05.050 – ident: 2023010523100927000_107.1.127.17 doi: 10.1167/iovs.12-9501 – volume: 64 start-page: 351 year: 2020 ident: 2023010523100927000_107.1.127.4 article-title: Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma publication-title: Jpn J Ophthalmol doi: 10.1007/s10384-020-00743-2 contributor: fullname: Kiratli – volume: 121 start-page: 517 year: 2014 ident: 2023010523100927000_107.1.127.5 article-title: Management and outcome of retinoblastoma with vitreous seeds publication-title: Ophthalmology doi: 10.1016/j.ophtha.2013.09.011 contributor: fullname: Manjandavida – volume: 124 start-page: 1817 year: 2017 ident: 2023010523100927000_107.1.127.12 article-title: Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma publication-title: Ophthalmology doi: 10.1016/j.ophtha.2017.05.034 contributor: fullname: Berry – ident: 2023010523100927000_107.1.127.10 |
| SSID | ssj0002617 |
| Score | 2.4827962 |
| Snippet | AimTo investigate whether the American Joint Committee on Cancer (AJCC) clinical category cT2b needs to be subclassified by the type and distribution of... To investigate whether the American Joint Committee on Cancer (AJCC) clinical category cT2b needs to be subclassified by the type and distribution of... Aim To investigate whether the American Joint Committee on Cancer (AJCC) clinical category cT2b needs to be subclassified by the type and distribution of... AIMTo investigate whether the American Joint Committee on Cancer (AJCC) clinical category cT2b needs to be subclassified by the type and distribution of... |
| SourceID | swepub pubmedcentral proquest crossref pubmed bmj |
| SourceType | Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 127 |
| SubjectTerms | Cancer therapies Chemotherapy Classification Clinical outcomes Clinical Science Dust Humans Infant Medicin och hälsovetenskap neoplasia Neoplasm Seeding Oncology Ophthalmology Optic nerve pathology retina Retinal Neoplasms - diagnosis Retinal Neoplasms - radiotherapy Retinoblastoma Retinoblastoma - diagnosis Retinoblastoma - radiotherapy Retrospective Studies Seeds Statistical analysis Treatment Failure Tumors vitreous Vitreous Body |
| SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEB6aDZReSt_dNC0q9FgR25L86KW0ISEEEkraQG5GsiV2k6y1iZ3_3xlb3tQESnvwxZL8mBlJnzSabwA-GWGdsInjmdCOy0pF3MSZ4JEWcW2ksrb3np-cpkfn8vhCXYQNtzYcqxzHxH6grn1Fe-R7SYYrGezVmfq6vuGUNYq8qyGFxhZsJ7hSiGaw_f3g9MfZZiwmvvEBAGc8RnAznuUR6Z659OtFt9DXK3-NtpLEFEick0t0y6wup9PUA-z58AjlhGi0n5wOn8HTgCrZt8EMnsMj27yAxyfBb_4Sfp5RZLM3CJU7v9KsxTmr_cKGEEnmGzY6btixXzYdo7CRZddZS2X7ZBi3bIyhZIgnKbPRKzg_PPi1f8RDOgVucJFDSec1kdnrvErzKreyNnHtKlVVUeIKp1EtRJ5vCyulc0YJJ42LUm1xTCgU8bK9hlnjG_sWGBYQC1DuEJ_IIha5M0lhRO1MlLo6qufAUYZl6A5t2a80RFr-KfOSZF4OMp_DZ6q_Hgg2_qF6PCrnP9rsjlq8_657o5rDx00xdjDymujG-jusoxDRKkRN-Ig3g9I3LxVSEF-YnEM2MYdNBSLvnpY0y0VP4l0khJSxZTIYzrQJTp5luH-1pKtsbdlTthLF4s7f_-UdPMEfF8NG0S7Muts7-x6hU2c-hP7xG-s-Gms priority: 102 providerName: ProQuest |
| Title | Retinoblastoma seeds: impact on American Joint Committee on Cancer clinical staging |
| URI | http://dx.doi.org/10.1136/bjophthalmol-2021-318892 https://www.ncbi.nlm.nih.gov/pubmed/34340974 https://www.proquest.com/docview/2754946775 https://search.proquest.com/docview/2557550152 https://pubmed.ncbi.nlm.nih.gov/PMC9205754 http://kipublications.ki.se/Default.aspx?queryparsed=id:148270371 |
| Volume | 107 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwEB5RkFAviLY8FujKSD02ahLbScwNViCEtKjiUW1PkZ3Y2gU2QWz4_8zksTSiqsohipKxnWjG9nzOZD4DfDPcOm5D58VcO09k0vdMEHPP1zzIjZDW1tHz8WV0fisuJnKyAuHfI_gBj36Yu_JxWk31w7x8QJuGASX8Jgqn3TWiLqfBqH7fLGdfYhhvIG_sBQhnur93_tESuhUzv-s7pjdo8-1Pkz1q0dodnW3CRosj2XFj-E-wYovPsD5uI-Vf4PqKcplLg-C4KueaLdBLLY5YkxTJyoJ1oRp2Uc6KilGiyKyqrCXZiLrCE-uyJhkiSNrLaAtuz05vRudeu4GCZ3BZQ9vMa6Kv10kWJVliRW6C3GUyy_zQKafREESXb5UVwjkjuRPG-ZG2OAsoSUxs27BalIXdBYYC4v1JHCISoQKeOBMqw3Nn_Mjlfj4AD3WYtgNgkdZrCx6lf-o8JZ2njc4H8J3KPzaUGv9RPOiM8446B50VX98Lu4xQ6BxiOYDDpRiHFMVJdGHLZywjEcNKxEnYxE5j9OVDueDEECYGEPe6w7IA0XX3JcVsWtN2q5CwMdYMm47Tr4LuMm3v38_oSBc2rUlaiVRx733q2oePeMWbT0UHsFo9PduvCJ4qM4QP8SQe1mNmCGvHo_H4F55PTi9_Xr0AEbYbPQ |
| link.rule.ids | 230,315,783,787,888,12068,21400,27561,27562,27868,27936,27937,31731,31732,33756,33757,43322,43817,55677,55678,74073,74630 |
| linkProvider | BMJ Publishing Group Ltd |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwELYKSG0vFfQBW6B1pR5rkcR2Hr0ghIq2lOXAQ9qbZSe2doGNtyT8_87ksTRCqughl9jOYzy2v_F4viHkq-HWcRs5lnDtmMhlwEyYcBZoHhZGSGsb7_nkPB5fi9OpnHYbblV3rLKfE5uJuvA57pEfRAlYMjCqE3m4_M0waxR6V7sUGmtkA3m4MINBMl0ZXA3beAt_ExYCtOlP8vD4wNz45aye6buFvwNNiUIMI07RIbpmFjfDReoJ8nx6gHJAM9osTSeb5E2HKelRqwRb5IUt35KXk85r_o5cXmBcszcAlGu_0LSCFav6TtsASepL2rtt6KmflzXFoJF5XVuLZceoFve0j6CkgCYxr9F7cn3y4-p4zLpkCsyAiYMp5zVS2es0j9M8taIwYeFymedB5DKnoVOQOt9mVgjnjOROGBfE2sKMkElkZftA1ktf2h1CoQA5gFIH6ERkIU-diTLDC2eC2BVBMSIMZKi6wVCpxs7gsfpb5gplrlqZj8g3rL9s6TWeUT3sO-c_2uz1vfj4XY8qNSJfVsUwvNBnokvrH6COBDwrATPBI7bbTl-9lAuObGFiRJKBOqwqIHX3sKSczxoK7yxCnAwto1Zxhk1g6VTd_ds5XqqyqiFsRYLFj__-l8_k1fhqcqbOfp7_2iWvQQi83TLaI-v1_YPdBxBVm0_NSPkDofwb9g |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dT9swELdGkdBeJvbdwTZP2uOiJrGdD17QxqgYGxViQ-LNshNbLaNxIeH_5y5xyiKkaXvIS2037fnO_tl39ztCPmpmLDOxDVKmbMALEQY6SlkQKhaVmgtjWu_5ySw5OufHF-LCxz_VPqyyXxPbhbp0Bd6RT-IUTjJg1amYWB8Wcfp1ur-6DrCCFHpafTmNDbKZ8oSFI7L55XB2erZel5F7vAPDaRAB0Onjelgy0ZduNW_m6mrprkBv4giTijN0j27o5eVwy3qAQx-GUw5IR9uNarpNnniEST93KvGUPDLVM7J14n3oz8nPM8xydhpgc-OWitawf9V7tEuXpK6ivROHHrtF1VBMIVk0jTHYdoBKckP7fEoK2BKrHL0g59PDXwdHgS-tEGg48GABeoXE9iorkqzIDC91VNpCFEUY29wqmCIk0je54dxaLZjl2oaJMrA-5AI52l6SUeUq85pQaEBGoMwCVuF5xDKr41yz0uowsWVYjkkAMpTeNGrZnjpYIv-UuUSZy07mY_IJ-686so1_6B71k_MfY3b7Wbz_XfcKNiYf1s1gbOhBUZVxt9BHALoVgKDgK151k75-KeMMucP4mKQDdVh3QCLvYUu1mLeE3nmMqBlGxp3iDIfARir9578X-MjayJa-FekW3_z9v7wnW2Am8se32fcd8hhkwLr7o10yam5uzVtAVI1-503lDsdCIZM |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Retinoblastoma+seeds%3A+impact+on+American+Joint+Committee+on+Cancer+clinical+staging&rft.jtitle=British+journal+of+ophthalmology&rft.au=Tomar%2C+AS&rft.au=Finger%2C+PT&rft.au=Gallie%2C+B&rft.au=Kivela%2C+T&rft.date=2023-01-01&rft.issn=1468-2079&rft.volume=107&rft.issue=1&rft.spage=127&rft_id=info:doi/10.1136%2Fbjophthalmol-2021-318892&rft.externalDocID=oai_prod_swepub_kib_ki_se_148270371 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1161&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1161&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1161&client=summon |